Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Gene Polymorphisms Affect the Effectiveness of Atorvastatin in Treating Ischemic Stroke Patients.

Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology - 1 Jan 2016

Yue Yun-Hua, Bai Xu-Dong, Zhang Hui-Jun, Li You-Mei, Hu Liang, Liu Ling-Yun, Mao Jie-Ping, Yang Xiao-Ying, Dila Na-Mu

Abstract excerpt

BACKGROUND/AIMS: The aim of the present study is to investigate whether the single nucleotide polymorphism (SNP) in lipid metabolism related genes would affect the effectiveness of atorvastatin in both Han and Uighur populations. METHODS: 200 ischemic stroke patients were treated with atorvastatin. The differences of blood lipid level and their ratios were measured. Six lipid related genes, HMGCR, APOA5, LPL,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anticholesteremic Agents
Share to Apolipoprotein A-V

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Atorvastatin

Share to Cholesterol Ester Transfer Proteins

Share to Hydroxymethylglutaryl CoA Reductases

Share to Lipoprotein Lipase

Share to Lipoproteins, HDL

Share to Proprotein Convertase 9

Source

Identifiers

PMID: 27415775
DOI: 10.1159/000445654

Genes

APOA5
CETP
LPL
HMGCR
LDLR
PCSK9

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Gene Polymorphisms Affect the Effectiveness of Atorvastatin in Treating Ischemic Stroke Patients.PMID 27415775Read ↗

Polymorphisms in CYP450 Genes and the Therapeutic Effect of Atorvastatin on Ischemic Stroke: A Retrospective Cohort Study in Chinese Population.Semantic proximity Read ↗

The association of lipid metabolism relative gene polymorphisms and ischemic stroke in Han and Uighur population of Xinjiang.Semantic proximity Read ↗

SNP of HMGCR and Apo E genes and their impact in response to statin therapy in hypercholesterolemic and hypertriglyceridemic patients in Pakistan.Semantic proximity Read ↗

Association of HMGCR rs17671591 and rs3761740 with lipidemia and statin response in Uyghurs and Han Chinese.Semantic proximity Read ↗

CYP7A1 polymorphism influences the LDL cholesterol-lowering response to atorvastatin.Semantic proximity Read ↗

Associations Between Gene Variants of Lipid-Lowering Drug Targets and Adverse Outcomes After Ischemic Stroke.Semantic proximity Read ↗

HMGCR and ApoE mutations may cause different responses to lipid lowering statin therapy.Semantic proximity Read ↗

Lipid Metabolism Genes in Stroke Pathogenesis: The AtherosclerosisSemantic proximity Read ↗

Gene-drug interactions identify genomic loci that enhance statin effectiveness in lowering LDL cholesterolSemantic proximity Read ↗

CYP3A4*1B and CYP3A5*3 SNPs significantly impact the response of Egyptian candidates to high-intensity statin therapy to atorvastatin.Semantic proximity Read ↗

Association between selected gene polymorphisms and statin metabolism, risk of ischemic stroke and cardiovascular disorders.Semantic proximity Read ↗

HMGCR gene polymorphism is associated with stroke risk in the EPIC-Norfolk study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.